ECMO for Pediatric ARDS
<p><strong><bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Objectives:</bold></strong> To review and assimilate the literature on children receiving...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2026
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1243697 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | <p><strong><bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Objectives:</bold></strong> To review and assimilate the literature on children receiving extracorporeal membrane oxygenation (ECMO) support for pediatric acute respiratory distress syndrome (PARDS).</p> <p><strong><bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Data sources:</bold></strong> German guideline for non obstructive Pediatric Respiratory Failure published in AWMF online.</p> <p><strong><bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Summary:</bold></strong> ECMO is used as a rescue therapy in children with severe PARDS who fail conventional management such as lung-protective ventilation and adjunctive therapies. Evidence suggests that ECMO can provide adequate oxygenation and allow lung rest while the underlying disease is treated. However, available studies are heterogeneous and mostly observational. Outcomes vary depending on patient characteristics, etiology of ARDS, and timing of ECMO initiation. Further prospective research is required to better define optimal patient selection, timing, and management strategies.</p>
<p><strong><bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Conclusion:</bold></strong> ECMO remains an important supportive therapy for selected children with severe ARDS refractory to conventional treatment, but stronger evidence is needed to guide clinical decision-making.</p> |
|---|---|
| ISBN: | 978-1-80631-421-8 |
| DOI: | 10.5772/intechopen.1014849 |